Meningococcal Meningitis

Bacterial Meningitis is a bacterial infection that invades the cerebrospinal fluid, the fluid that surrounds the brain and spinal cord. It is spread by direct contact with infected individuals and through infected droplets in the air.

  • Severe headache (unrelenting for > 24 hours)
  • Generalized muscle aches and pain
  • Nausea
  • Vomiting
  • Diarrhea
  • Fever
  • Chills
  • Elevated heart rate
  • Red rash
Meningococcal Vaccine

The meningococcal vaccine (MCV4) protects against some types of meningitis. Two doses are currently recommended to decrease the risk of disease with the first vaccination ideally at age 11-12 years with a booster dose at age 16 years. Vaccination does not guarantee complete protection because of the variety of strains of meningitis.

The vaccine has minimal side effects such as soreness at the injection site. A small percent of people develop a slight fever. If a persistent fever develops, call your health care provider.

Meningococcal Vaccine is recommended for:
  • College students living in residence halls.

Serogroup B meningococcal (MenB) vaccines can help prevent meningococcal disease caused by serogroup B. These vaccines are recommended routinely for people who are at increased risk for serogroup B meningococcal infections. They may also be given to anyone 16 through 23 years old to provide short term protection against most strains of serogroup B meningococcal disease; 16 through 18 years are the preferred ages for vaccination. Men B vaccines (Trumenba or Bexsero) can be ordered and administered by Health Services for a fee. Please contact Health Services at for additional pricing information.